Reset filters
  • 12 July 2004

Tenofovir has viral potency, a good lipid and safety profile, and should be available for first line HAART says study

Read the article
  • 8 July 2004

FDA warns that tenofovir has not been proven to be safe for HIV/HBV coinfection

Read the article
  • 6 July 2004

Thickness of fat around the kidneys predicts which HIV-positive patients will get lipodystrophy

Read the article
  • 6 July 2004

Viral load above 100,000 linked with risk of severe side-effects in people taking PI-based HAART

Read the article
  • 21 June 2004

Risk of severe liver toxicities if nevirapine used in HAART in pregnant women with CD4 above 250

Read the article
  • 18 June 2004

Over a quarter of HIV-positive children on treatment have lipodystrophy in European study

Read the article
  • 11 June 2004

New report on palliative care and HIV: recommendations and resources

Read the article
  • 8 June 2004

French IV drug users who report HAART side-effects have more risky sex

Read the article
  • 28 May 2004

Atazanavir significantly reduces lipids 12 weeks after switching from nelfinavir

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.